Key result
The Japanese cuisine-based DASH (J-DASH) diet significantly reduced home morning systolic blood pressure by 5.7 mmHg compared to a usual diet in participants with untreated high-normal blood pressure or stage 1 hypertension.
Why the study?
Following a previous single-arm trial of the Japanese cuisine-based DASH diet, this study aimed to test its feasibility based on effects on blood pressure and blood pressure variability in untreated high-normal blood pressure or stage 1 hypertension.
Does a Japanese cuisine-based DASH diet improve blood pressure and its variability in participants with untreated high-normal blood pressure or stage 1 hypertension?
RCT (n=40)
Open-label (single-masking for outcome assessors)
Central allocation, 1:1:1 ratio
No
Does a Japanese cuisine-based DASH diet improve blood pressure and its variability in participants with untreated high-normal blood pressure or stage 1 hypertension?
A Japanese cuisine-based DASH diet is feasible and effectively lowers home blood pressure and its variability in patients with untreated high-normal blood pressure or stage 1 hypertension.
J-DASH diet feasible for BP lowering in high-normal/stage 1 hypertension; leaves open efficacy confirmation in larger RCTs.
AIM: The Dietary Approaches to Stop Hypertension (DASH) diet is recommended for lowering blood pressure (BP). Our previous single-arm trial revealed that the Japanese cuisine-based DASH (J-DASH) diet (supplying NaCl 8.0 g per day) reduced BP and improved cardiometabolic biomarkers. The present study's primary objective was to test the feasibility of the J-DASH diet based on its effects on the BP and BP variability of subjects with untreated high-normal BP or stage 1 hypertension. METHODS: The 6-month study period was held from December 2015 to August 2016. The participants were recruited through advertisements in local newspapers and our website and from among randomized participants at Yamaguchi University Hospital. The 2-month treatments included the following: the J-DASH-1 diet 1×/day or the J-DASH-2 diet providing a fish hamburger-patty 2×/day (5 days/week respectively). The control group consumed their usual diets. For the subsequent 4 months, all participants consumed their usual diets. The main outcome measure was the feasibility of the J-DASH diet. We also collected the data of clinic BP and home BP (by automatic BP monitor), cardiometabolic biomarkers, and lifestyle and psychosocial parameters during the intervention phase. We examined behavior changes throughout the study period, and the diets' safety. RESULTS: Fifty-one participants were recruited; following screening, 48 met the inclusion criteria and were randomized by central allocation. Eight participants were eliminated based on exclusion criteria, and the 40 participants were randomly allocated to the J-DASH 1 and J-DASH 2 groups ( n=13 each) and the usual-diet group (n=14). The participants' mean age was 50 years, and 44% were women. The three groups' clinic BP values were not significantly different, but the home BP values were lower in the J-DASH 1 group and lowest in the J-DASH 2 group compared to the usual-diet group and differed significantly among the three groups throughout the study period (p<0.0001). The home BP variability was significantly lower in the J-DASH groups compared to the usual-diet group throughout the study period ( p<0.01). The other indices including fish oil showed little differences among the groups throughout the study period. CONCLUSIONS: The J-DASH diet was feasible to improve home BP and stabilize its variability, and it did so more effectively than the participants' usual diets.
No takes yet. Share an insight, caveat, or question.
Umemoto et al. (2020) conducted an RCT in Untreated high-normal blood pressure or stage 1 hypertension (n=40). Japanese cuisine-based DASH (J-DASH) diet vs. Usual diet was evaluated on Home morning systolic blood pressure (MD -5.7 mmHg, p=<0.0001). The Japanese cuisine-based DASH (J-DASH) diet significantly reduced home morning systolic blood pressure by 5.7 mmHg compared to a usual diet in participants with untreated high-normal blood pressure or stage 1 hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Hypertension managementMore from Journal of Atherosclerosis and Thrombosis